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Question & Answer
Q Q& &A A: :   E Ep pi is st ta as si is s
Frederick P Roth*, Howard D Lipshitz† and Brenda J Andrews†,‡
W Wh ha at t   i is s   e ep pi is st ta as si is s? ?
Hmmm. Are you a classical geneticist,
a population geneticist, or a medical
doctor?
O OK K, ,   w wh ha at t   d do oe es s   a a   c cl la as ss si ic ca al l
g ge en ne et ti ic ci is st t   m me ea an n   b by y   e ep pi is st ta as si is s? ?
William Bateson coined this term
about 100 years ago for a genetic
interaction in which one mutation
masks or suppresses the effects of
another allele at another locus [1].
W Wh ha at t   d do o   y yo ou u   m me ea an n   e ex xa ac ct tl ly y   b by y   a a
g ge en ne et ti ic c   i in nt te er ra ac ct ti io on n? ?
Two mutations have a genetic inter-
action when their combination yields
a surprising phenotype that cannot be
explained simply by the independent
effects observed for each mutation
alone.
F Fi in ne e, ,   s so o   w wh ha at t   d do oe es s   a a   p po op pu ul la at ti io on n
g ge en ne et ti ic ci is st t   m me ea an n   b by y   e ep pi is st ta as si is s? ?
RA Fisher used ‘epistacy’ and later
‘epistasis’ to describe genetic inter-
actions more generally [2]. We think
that population geneticists hijacked
this term over a decade after its
coinage just to confuse the classical
geneticists.
O OK K, ,   w wh ha at t   d do oe es s   a a   m me ed di ic ca al l   d do oc ct to or r
m me ea an n   b by y   e ep pi is st ta as si is s? ?
A thin film on the surface of a urine
specimen. Enough said on that topic.
I I’ ’m m   c co on nf fu us se ed d. .   E Ep pi is st ta as si is s   s se ee em ms s   t to o
m me ea an n   g ge en ne et ti ic c   i in nt te er ra ac ct ti io on n   u un nd de er r   b bo ot th h
c cl la as ss si ic ca al l   a an nd d   p po op pu ul la at ti io on n   g ge en ne et ti ic cs s
d de ef fi in ni it ti io on ns s. .   W Wh ha at t’ ’s s   t th he e   d di if ff fe er re en nc ce e? ?
Epistasis under the classical definition
describes only interactions in which
one mutant phenotype is masked or
suppressed in the presence of the other
mutation. The population geneticist’s
definition includes classical epistasis,
but also encompasses ‘aggravating’ or
‘synthetic’ interactions - where two
mutations together yield a surprisingly
deleterious phenotype [3].
O OK K, ,   y yo ou u’ ’v ve e   d de ef fi in ne ed d   e ep pi is st ta as si is s. .   B Bu ut t
w wh hy y   s sh ho ou ul ld d   I I   c ca ar re e   a ab bo ou ut t   i it t? ?
Epistasis, in the classical sense, pro-
vides a logical framework for inferring
biological pathways from biochemical
and other experiments, because it
suggests that two genes are working
within the same pathway and some-
times in what order they act. This
makes epistasis analysis a very impor-
tant tool in functional genomics
experiments where pairs of genes are
systematically deleted so that any
interactions can be detected and
interpreted in terms of biological
interactions or pathways [4]. Epistasis
analysis has already informed our
understanding of the components and
their order of action in every
biological process we can think of.
E Ev ve er ry y   b bi io ol lo og gi ic ca al l   p pr ro oc ce es ss s   y yo ou u c ca an n
t th hi in nk k   o of f, ,   m ma ay yb be e, ,   b bu ut t   t th ha at t   d do oe es sn n’ ’t t   h he el lp p
m me e. .   W Wh ha at t   k ki in nd d   o of f   p pr ro oc ce es ss s   a ar re e   y yo ou u
t ta al lk ki in ng g   a ab bo ou ut t? ?   A An nd d   w wh hy y   d do oe es sn n’ ’t t
n no on n- -c cl la as ss si ic ca al l   e ep pi is st ta as si is s   t te el ll l   y yo ou u   a ab bo ou ut t
p pa at th hw wa ay ys s   t to oo o? ?
All right, let us give you two examples.
First, the yeast genes BNI1 and BNR1,
which encode so-called formin
proteins involved in the nucleation of
actin filaments, have an aggravating
genetic interaction (epistasis in the
non-classical sense). A mutation in
either  BNI1 or  BNR1 causes cell
polarity defects, but the yeast remain
viable. However, deletion of both
BNI1 and  BNR1 in the same cells
causes lethality (that is, they have a so-
called synthetic lethal phenotype).
The BNI1 and BNR1 pair exemplifies
an aggravating interaction - and the
information to be gained from non-
classical epistasis more generally.
By contrast, we can look at an example
of classical epistasis from the nematode
worm Caenorhabditis elegans, in which a
well studied genetic pathway controls
the fate of ‘Pn’ cells that differentiate to
form the hermaphrodite worm’s vulva.
These cells undergo three sequential
differentiation steps, first into ‘Pn.p’
cells, then into VPC cells, and finally
into vulval cells (Figure 1). Three genes
control these steps: lin-26, lin-39 and let-
23. In lin-26 mutants you don’t get Pn.p
cells, while in lin-39 single mutants you
don’t get VPC cells and in let-23
mutants you don’t get vulval cells. In
lin-26 +  lin-39 double-mutants you
don’t get Pn.p cells, so the double
mutant looks like the lin-26 mutant -
Journal of Biology 2009, 8 8: :35
Address: *Harvard Medical School,
Department of Biological Chemistry and
Molecular Pharmacology, 250 Longwood
Avenue, Boston, MA 02115, USA.
†Department of Molecular Genetics and
‡Donnelly Centre for Cellular and
Biomolecular Research, the University of
Toronto, Toronto, ON, Canada M5S 3E1.that is, the effect of lin-39 is masked by
the effect of lin-26, and thus lin-26 is
‘epistatic to’, and upstream of, lin-39;
similarly, in lin-39 +  let-23 double
mutants you don’t get VPC cells, so lin-
39 is epistatic to, and upstream of, let-
23. In a formal sense, this cell fate
pathway is similar to a biosynthetic
pathway in which the product of one
gene’s action becomes the substrate for
the next gene and so on. In such
pathways, the predominating mutation
is always epistatic to the masked or
suppressed mutation. The masked or
suppressed mutation is said to be
‘hypostatic to’ the predominating
mutation.
S So o   t th he e   e ep pi is st ta at ti ic c   g ge en ne e   a al lw wa ay ys s   a ac ct ts s
u up ps st tr re ea am m   o of f   o or r   b be ef fo or re e   t th he e   h hy yp po os st ta at ti ic c
g ge en ne e   i in n   t th he e   p pa at th hw wa ay y? ?
Not always. This is a good rule of
thumb for positive regulatory pathways,
like the one in the example we have
just given, in which each step provides
the basis for the next, or for
biosynthetic pathways where genes
encode enzymes that convert a
substrate into a product.
I If f   e ep pi is st ta at ti ic c   m mu ut ta at ti io on ns s   a ar re en n’ ’t t   a al lw wa ay ys s
u up ps st tr re ea am m, ,   w wh he en n   w wo ou ul ld d   a an n   e ep pi is st ta at ti ic c
m mu ut ta at ti io on n   a ac ct t   d do ow wn ns st tr re ea am m? ?
When the upstream gene product
represses the downstream gene product,
rather than activating it (or providing a
substrate for it). Consider a two-step
gene regulatory pathway in which gene
X represses gene Y. Let’s say that gene Y
causes fur to grow on the tip of a
heffalump’s nose (Figure 2). But of
course you know that heffalumps do
not have fur growing from the tip of
their noses; and this is because gene X
represses gene Y. So, a mutation in gene
X will result in failure to repress Y and
thus the heffalump’s nose-tip will be
furry. In contrast, a mutation in Y
would result in lack of fur on the tip of
the nose, since Y is required for fur
growth. In the double-mutant, since Y
function is abrogated it no longer
matters that X isn’t there to repress Y,
and the nose tip will be beautifully bald
(as it should be). In this case, mutations
in Y are epistatic to mutations in X, even
though Y acts downstream of X.
B Bu ut t   h ho ow w   d do o   I I   k kn no ow w   w wh he et th he er r   I I   a am m
d de ea al li in ng g   w wi it th h   a a   p po os si it ti iv ve e- -r re eg gu ul la at to or ry y   o or r
b bi io os sy yn nt th he et ti ic c   p pa at th hw wa ay y, ,   o or r   a a   n ne eg ga at ti iv ve e
r re eg gu ul la at to or ry y   p pa at th hw wa ay y, ,   i in n   w wh hi ic ch h   t th he e
i in nt te er rp pr re et ta at ti io on ns s   o of f   e ep pi is st ta as si is s   a ar re e   p po ol la ar r
o op pp po os si it te es s? ?
The diagnostic sign of a negative
regulatory pathway is that mutations at
different steps of the pathway result in
opposite phenotypes. For this reason,
Linda Huang and Paul Sternberg refer
to negative regulatory pathways as
‘switch regulation pathways’ [5]. This is
true of our heffalump pathway above,
where a mutation in one step gives a
hairy nose tip and a mutation in the
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Classical epistasis in the vulval differentiation pathway of C. elegans.
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cellsnext a bald nose tip. A real-life example
is sex determination in C. elegans, in
which there are two sexes,
hermaphrodites, which are XX, and
males, which are XO. Maleness is
determined by a secreted protein, HER,
which inactivates a membrane protein,
TRA, which represses genes that are
required for male characters (Figure 3).
Mutations that cause loss of function in
her, the gene encoding HER, cause XO
animals to look female, but have no
effect on XX animals, because HER is
not required for the expression of
hermaphrodite characters. In contrast,
tra loss-of-function mutations cause XX
animals to become male instead of
hermaphrodite, because TRA is required
for the expression of hermaphrodite
characters; but XO animals become
male just as they should. Double
mutants (tra +  her) look like tra
mutants: XX animals become male. So
tra is epistatic to her and is downstream
of  her, because this is clearly a switch
pathway.
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Epistasis in the nose-tip fur of Heffalumpus.
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Classical epistasis in the sex determination pathway of C. elegans.
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stream relationship exhibits an
‘epistatic to’ relationship. For example,
two mutant genes may yield the same
phenotype if, for example, one gene
product is required to recruit the other
into an active complex. In such cases,
we might expect the double mutation
to yield the same pathway-disrupting
phenotype as either alone. This kind
of genetic interaction has been called
‘complementary gene action’,
although some prefer the term ‘co-
equality’ [6].
S So o   h ho ow w   c ca an n   y yo ou u   l le ea ar rn n   a ab bo ou ut t
p pa at th hw wa ay y   o or rd de er r   w wh he en n   m mu ut ta at ti io on n   o of f
e ei it th he er r   g ge en ne e   y yi ie el ld ds s   t th he e   s sa am me e
p ph he en no ot ty yp pe e? ?
Even if both genes have mutants with
the same phenotype, there may be
other mutations that enable pathway
ordering via epistasis analysis.
Specifically, if you can find a mutation
that causes a gain of function - for
example, by constitutively activating a
gene product that normally requires
activation. Consider the genes that
specify the fates of cells at the termini of
the Drosophila embryo so that they are
distinct from those in the central region
of the embryo. A ligand present only at
the termini activates a receptor tyrosine
kinase, encoded by the torso gene
(Figure 4). The activated kinase initiates
a signal transduction cascade that
ultimately activates transcription of the
tailless gene in the termini. The tailless
gene encodes a transcriptional regulator
that directs terminal-cell fates and
represses central-cell fates in the
termini. Thus, loss-of-function muta-
tions in torso (torsolof) and tailless
(taillesslof) have very similar phenotypes:
the cells at the termini adopt central
fates, and classical epistasis is not
immediately possible. Epistasis was
made possible by the discovery of
constitutive gain-of-function mutations
in torso (torsogof) in which all cells in the
embryo adopt terminal fates [7]. HJ
Muller referred to this type of mutation
in 1932 as ‘hypermorphic’ [8]. The
torsogof taillesslof double-mutant pheno-
type was identical to that of taillesslof,
enabling the gene order to be depicted
as drawn in Figure 4. Obviously, the
constitutive activation of the torso
kinase has no effect when the down-
stream tailless gene is inactivated.
On the other hand, mutations that
don’t cause complete loss of function
can be a problem. Let’s go back to the
nematode sex-determining pathway in
which HER negatively regulates TRA.
But now assume that while the tra
mutations are null, the ones in her are
leaky - or hypomorphic, in the
terminology (also devised by HJ Muller
in 1932 [8]). The normal function of
HER is to turn off TRA. So in a her
mutant, TRA is turned on. Now in a
double mutant in which the tra allele is
null, you get XX animals becoming
male, as described above, and so tra is
epistatic to her. But if the tra allele is not
null, then in the double mutant the XX
animals may still take on some
hermaphrodite character together with
some male character, so the epistatic
relationship would be unclear.
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Epistasis or ‘suppression’ of a gain-of-function mutation in Drosophila. In early Drosophila
development, the terminal cells differentiate from the central cells in response to signaling
through the Torso protein, a receptor tyrosine kinase that is expressed on all the cells of the
developing embryo. Torso signaling is confined to the termini through localized release (or
processing) of Torso’s ligand, which activates the receptor, resulting ultimately in transcription of
the tailless gene. Tailless is a transcriptional regulator that specifies terminal cell fates and
represses central cell fates. In torso loss-of-function mutants (torsolof), all cells develop as central
cells. In torso gain-of-function mutants (torsogof), the receptor is constitutively active and all cells
develop as terminal cells. In the double mutant, loss of tailless function masks the effect of the
torso gain-of-function mutation and all the cells differentiate as central cells.
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(ubiquitous receptor)A As s   f fa ar r   a as s   I I   c ca an n   s se ee e, ,e ep pi is st ta as si is s   a an na al ly ys si is s
w wo or rk ks s   p pr ro op pe er rl ly y   o on nl ly y   i if f   y yo ou u   a al lr re ea ad dy y
k kn no ow w   t th he e   p pa at th hw wa ay y   f fu un nc ct ti io on ns s   - -   s so o
w wh ha at t   u us se e   i is s   i it t? ?
Not at all! Taking the torso pathway as
an example, the remarkable thing is that
the pathway was figured out using
genetic experiments before either gene
was cloned and found to be in the one
case a receptor and in the other a trans-
cription factor. Genetic and molecular
experiments complement each other: if
only molecular biology were available,
there would have been no way of
linking the receptor and the trans-
cription factor in regulating the same
developmental event; while, if only
genetics had been available, then no
understanding of the mechanism would
have been possible. As another example,
the first-known microRNA, lin-4, was
first shown to be a repressor of its target
gene, lin-14, based largely on the obser-
vation that lin-14 null mutations cause a
phenotype opposite to that of lin-4(lf)
and are epistatic to lin-4(lf) [9].
D Do o   a al ll l   g ge en ne es s   t th ha at t   w wo or rk k   t to og ge et th he er r
n ne ee ed d   t to o   h ha av ve e   a an n   u up ps st tr re ea am m- -
d do ow wn ns st tr re ea am m   r re el la at ti io on ns sh hi ip p? ?
No. Although some co-equal inter-
actions may correspond to upstream-
downstream relationships that may be
revealed when the right mutation
comes along, many may simply corres-
pond to genes that are working together
as a cohesive unit. For example, a syste-
matic genetic analysis of a well studied
set of DNA repair genes found nine
out of ten co-equal genetic interac-
tions corresponded to protein interac-
tions [6], and these included a ‘clique’
of co-equal interactions amongst all
pairs of the four genes encoding a
single complex (the SHU complex).
N No ow w   I I   u un nd de er rs st ta an nd d   w wh ha at t   e ep pi is st ta as si is s   i is s, ,
a an nd d   h ho ow w   t to o   a an na al ly yz ze e   i it t, ,   w wh ha at t   s so or rt t   o of f
a ap pp pl li ic ca at ti io on ns s   m mi ig gh ht t   i it t   h ha av ve e? ?
As we have already said, there has been
a recent wave of information from
functional genomics experiments, inclu-
ding efforts to systematically map genetic
interactions. The availability of these
data, combined with information on
genome variation from next generation
sequencing and other techniques,
means that we have a remarkable
opportunity to apply genetic analysis to
reveal components and order of action
in biological systems on a global scale.
Systematic study of pairwise inter-
actions is now feasible, and for geneti-
cally accessible systems such as yeast
may even encompass all gene pairs.
W Wh ha at t   s so or rt t   o of f   t th hi in ng g   c ca an n   b be e   l le ea ar rn ne ed d
f fr ro om m   a an na al ly ys si is s   o of f   s sy ys st te em ma at ti ic c   i in nt te er ra ac ct ti io on n
d da at ta a? ?
One kind of analysis is comparison of
genetic interaction profiles. For
example, if gene A has 12 synthetic
lethal interaction partners, and gene B
has synthetic lethal interaction with the
same 12 genes, their genetic interaction
profiles are entirely overlapping.
Indeed, several systematic studies have
now clearly shown that clusters of
genes with similar profiles often
correspond to protein complexes or
other biochemical modules, leading to
many specific (and subsequently
confirmed) biochemical predictions
[10-12]. As just one example,
YMR299C (now called DYN3) was
predicted on this basis to be part of the
dynein-dynactin pathway, which is
involved in spindle assembly, nuclear
movement and spindle orientation
during cell division [8], a prediction
later confirmed [13].
I In n   h hi ig gh h   s sc ch ho oo ol l   I I   h ha at te ed d   l lo og gi ic c. .   C Ca an n   I I   s st ti il ll l
d do o   e ep pi is st ta as si is s   a an na al ly ys si is s? ?
Maybe. But you may wish to consider
alternatives such as a career in politics
or, failing that, investment banking.
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